Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF132 divergent transcript (ZNF132-DT) is a long non-coding RNA gene situated in proximity to the ZNF132 protein-coding gene; it is transcribed in the direction opposite to ZNF132 from a shared promoter region. Such lncRNAs, known as divergent transcripts, are often involved in the regulation of the expression of neighboring protein-coding genes and may play roles in chromatin organization or transcriptional control[2][5]. There are currently no drugs, biomarkers, or established clinical utility associated with ZNF132-DT, and it is not recognized as a protein, enzyme, or canonical therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZNF132 divergent transcript (ZNF132-DT).